The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Moore Paul Andrew since 2024.
This trader's CIK number is 1938192.
At the time of last reporting, Moore Paul Andrew was the Chief Scientific Officer of Zymeworks Inc.. (stock ticker symbol ZYME).
Also see all insider trading activities at Zymeworks Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ZYME | 0 | $0 | 21,200 | $316,388 | 37,166 | $0 |
| 2024 | ZYME | 0 | $0 | 9,799 | $105,697 | 17,166 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-06 | ZYME | Option Ex | 37,166 | .00 | 0 |
| 2025-01-06 | ZYME | Sale | 21,200 | 14.92 | 316,388 |
| 2024-01-08 | ZYME | Sale | 2,339 | 11.22 | 26,234 |
| 2024-01-05 | ZYME | Sale | 7,460 | 10.65 | 79,463 |
| 2024-01-05 | ZYME | Option Ex | 17,166 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moore Paul Andrew (Chief Scientific Officer of Zymeworks Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.